Prevacid Delayed Release Drug Gets Another Generic Approval From the FDA–Dr. Reddy’s
Posted Oct 17 2010 12:41pm
Dr. Reddy is located in India and the FDA has now approved their generic version of Lansoprazole for the treatment of ulcers and Dr. Reddy states the product should be available shortly. BD
New Delhi, Oct 16 (PTI) Dr Reddy''s Laboratories today said it has received an approval from the US health regulator to sell a generic version of Takeda Pharmaceuticals ''Prevacid delayed release capsules'' in the US market. The company has received approval from the US Food and Drug Administration to launch Lansoprazole delayed released capsules in strengths of 15 and 30 mg, Dr Reddy''s Laboratories said in a statement.
Dr. Reddy is located in India and the FDA has now approved their generic version of Lansoprazole for the treatment of ulcers and Dr. Reddy states the product should be available shortly. BD